1. Home
  2. CRSP vs SPHR Comparison

CRSP vs SPHR Comparison

Compare CRSP & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$50.34

Market Cap

4.8B

Sector

Health Care

ML Signal

N/A

Logo Sphere Entertainment Co.

SPHR

Sphere Entertainment Co.

N/A

Current Price

$121.17

Market Cap

4.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
CRSP
SPHR
Founded
2013
2020
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.4B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
CRSP
SPHR
Price
$50.34
$121.17
Analyst Decision
Buy
Buy
Analyst Count
23
13
Target Price
$85.42
★ $154.00
AVG Volume (30 Days)
★ 1.3M
874.9K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
$289,590,000.00
★ $1,220,045,000.00
Revenue This Year
$910.97
$9.53
Revenue Next Year
$277.83
$0.74
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 9169.85
N/A
52 Week Low
$44.12
$73.03
52 Week High
$63.45
$181.63

Technical Indicators

Market Signals
Indicator
CRSP
SPHR
Relative Strength Index (RSI) 47.79 57.57
Support Level $50.02 $102.44
Resistance Level $60.68 $148.98
Average True Range (ATR) 2.44 6.55
MACD 0.06 2.44
Stochastic Oscillator 36.10 83.57

Price Performance

Historical Comparison
CRSP
SPHR

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About SPHR Sphere Entertainment Co.

Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments: Sphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.

Share on Social Networks: